Clinical Trials · NCT06351748
Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 34,238
- Start date
- Jan 2024
- Locations
- 1 site, China
- Primary endpoint
- Change in Haemoglobin A1c (HbA1c) level